Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Restructuring Costs (2024 - 2025)

Historic Restructuring Costs for Bicycle Therapeutics (BCYC) over the last 2 years, with Q3 2025 value amounting to $2.5 million.

  • Bicycle Therapeutics' Restructuring Costs fell 229.16% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.6 million, marking a year-over-year change of. This contributed to the annual value of $9.0 million for FY2024, which is 98.5% down from last year.
  • According to the latest figures from Q3 2025, Bicycle Therapeutics' Restructuring Costs is $2.5 million, which was down 229.16% from $2.3 million recorded in Q2 2025.
  • Bicycle Therapeutics' Restructuring Costs' 5-year high stood at $2.6 million during Q4 2024, with a 5-year trough of $1.9 million in Q2 2024.